TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 Immunotherapy
"TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 Immunotherapy" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Lea Dutta (ORCID: https://orcid.org/0000-0003-2864-3617)
- Antonio González-Martı́n (ORCID: https://orcid.org/0000-0001-8376-9576)
- Chinyere E. Okpara (ORCID: https://orcid.org/0000-0002-5621-9138)
- Alexandra Léary (ORCID: https://orcid.org/0000-0002-2043-2244)
- Bradley R. Corr (ORCID: https://orcid.org/0000-0002-6608-2585)
- Xiaohua Wu (ORCID: https://orcid.org/0000-0002-7664-8327)
- Helen J MacKay (ORCID: https://orcid.org/0000-0001-6220-1789)
- Domenica Lorusso (ORCID: https://orcid.org/0000-0003-0981-0598)
- Ramez N. Eskander (ORCID: https://orcid.org/0000-0002-2101-1935)
- Jodi A. McKenzie (ORCID: https://orcid.org/0000-0002-6345-1218)
- Isabelle Laure Ray-Coquard (ORCID: https://orcid.org/0000-0003-2472-8306)
- Jung‐Yun Lee (ORCID: https://orcid.org/0000-0001-7948-1350)
- Vicky Makker (ORCID: https://orcid.org/0000-0001-9793-7614)
- Kosei Hasegawa (ORCID: https://orcid.org/0000-0002-1903-7001)
- Tianle Hu
- Mansoor Mirza
- Ana Oaknin
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Sunnybrook Health Science Centre (CA)
- Memorial Sloan Kettering Cancer Center (US)
- Humanitas University (IT)
- University of Toronto (CA)
- Yonsei University (KR)
- Cornell University (US)
- Severance Hospital (KR)
- Institut Gustave Roussy (FR)
- Rigshospitalet (DK)
- University of California San Diego (US)
- Fudan University Shanghai Cancer Center (CN)
- Centre Léon Bérard (FR)
- Vall d'Hebron Hospital Universitari (ES)
- Clinica Universidad de Navarra (ES)
- Eisai (United Kingdom) (GB)
- Eisai (United States) (US)
- Vall d'Hebron Institute of Oncology (ES)
- University of Colorado Anschutz Medical Campus (US)
- Saitama Medical University (JP)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7252
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05